Profit From The Genomics Market Momentum With These ETFs

The healthcare landscape has been benefiting from advancements in genomics which is helping to understand the function, structure, evolution, editing and mapping of genomes. The global genomics market is being favored by a streak of solid developments in sequencing, microarray, PCR (Polymerase Chain Reaction), nucleic acid extraction and purification techniques. Also, the implications of AI, cloud-based technologies and increased R&D focus are lending a competitive edge to the companies with significant exposure to genomics.

The latest developments in the genomics space highlight its role in making diagnostic tests for the coronavirus. In this regard, GlaxoSmithKline’s GSK consumer products division has recently partnered with Mammoth Biosciences to develop a new CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-based at-home COVID-19 test which would be fast, hand-held and fully disposable (per a FierceBiotech report). Moreover, the FDA has also awarded an emergency COVID-19 authorization to Sherlock Biosciences’ CRISPR-based, high-throughput lab test (per a FierceBiotech report).

Factors Supporting the Genomics Market

The application of human genomics studies across several public health programs like population screening and consumer wellness programs might create new opportunities. Notably, programs like these mainly aim at enhancing preventive care for common chronic diseases such as cancer and heart disease, per a Grand View Research report.

Moreover, with the support of new technologies the market is seeing decreasing sequencing costs and widening genomics-based applications. The genomics market is also seeing a ramp-up in government spending with a huge number of start-ups entering the market. Partnerships between research institutes and companies are also opening up new growth opportunities in the global genomics market.

Tremendous progress is being observed within the gene editing space as well. Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. In fact, going by a Zion Market Research report, the $3.7-billion global genome editing market of 2018 is expected to reach $9.66 billion by 2025, at a CAGR of 14.7%.

1 2 3
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.